SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001564590-22-011064
Filing Date
2022-03-18
Accepted
2022-03-18 16:15:53
Documents
6

Document Format Files

Seq Description Document Type Size
1 424B5 abio-424b5.htm 424B5 815851
2 GRAPHIC ge1wnzo4hxex000005.jpg GRAPHIC 99330
3 GRAPHIC ge1wnzo4hxex000004.jpg GRAPHIC 2926
4 GRAPHIC ge1wnzo4hxex000003.jpg GRAPHIC 8908
5 GRAPHIC ge1wnzo4hxex000001.jpg GRAPHIC 2926
6 GRAPHIC ge1wnzo4hxex000002.jpg GRAPHIC 99330
  Complete submission text file 0001564590-22-011064.txt   1111326
Mailing Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021
Business Address 10170 CHURCH RANCH WAY SUITE 100 WESTMINSTER CO 80021 7209402200
ARCA biopharma, Inc. (Filer) CIK: 0000907654 (see all company filings)

IRS No.: 363855489 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-254585 | Film No.: 22752727
SIC: 2835 In Vitro & In Vivo Diagnostic Substances